TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Jade Biosciences to Participate in Upcoming Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jade Biosciences
Jade Biosciences to Participate in Upcoming Conferences

Jade Biosciences, a clinical-stage biotechnology company, announced participation in multiple healthcare conferences in November 2025 and provided updates on its autoimmune disease therapy pipeline, including JADE101 and JADE201.

Insights
BMLpG   positive

First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends


JBIO   positive

Company is actively presenting at multiple conferences, showcasing ongoing clinical development of pipeline candidates targeting autoimmune diseases, indicating forward momentum and research progress